PMID- 34233864 OWN - NLM STAT- MEDLINE DCOM- 20211220 LR - 20230207 IS - 1878-1705 (Electronic) IS - 1567-5769 (Print) IS - 1567-5769 (Linking) VI - 101 IP - Pt B DP - 2021 Dec TI - MCP-1: Function, regulation, and involvement in disease. PG - 107598 LID - S1567-5769(21)00234-4 [pii] LID - 10.1016/j.intimp.2021.107598 [doi] AB - MCP-1 (Monocyte chemoattractant protein-1), also known as Chemokine (CC-motif) ligand 2 (CCL2), is from family of CC chemokines. It has a vital role in the process of inflammation, where it attracts or enhances the expression of other inflammatory factors/cells. It leads to the advancement of many disorders by this main mechanism of migration and infiltration of inflammatory cells like monocytes/macrophages and other cytokines at the site of inflammation. MCP-1 has been inculpated in the pathogenesis of numerous disease conditions either directly or indirectly like novel corona virus, cancers, neuroinflammatory diseases, rheumatoid arthritis, cardiovascular diseases. The elevated MCP-1 level has been observed in COVID-19 patients and proven to be a biomarker associated with the extremity of disease along with IP-10. This review will focus on involvement and role of MCP-1 in various pathological conditions. CI - Copyright (c) 2021 Elsevier B.V. All rights reserved. FAU - Singh, Sanjiv AU - Singh S AD - Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Export Promotion Industrial Park (EPIP), Zandaha Road, Hajipur, Bihar, India. Electronic address: sanjivpg2006@yahoo.com. FAU - Anshita, D AU - Anshita D AD - Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Export Promotion Industrial Park (EPIP), Zandaha Road, Hajipur, Bihar, India. FAU - Ravichandiran, V AU - Ravichandiran V AD - Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Export Promotion Industrial Park (EPIP), Zandaha Road, Hajipur, Bihar, India. LA - eng PT - Journal Article PT - Review DEP - 20210520 PL - Netherlands TA - Int Immunopharmacol JT - International immunopharmacology JID - 100965259 RN - 0 (Biomarkers) RN - 0 (CCL2 protein, human) RN - 0 (Chemokine CCL2) SB - IM MH - Animals MH - Biomarkers MH - Chemokine CCL2/genetics/*immunology/physiology MH - Chemotaxis MH - Disease MH - Humans MH - Monocytes/physiology MH - Oxidative Stress PMC - PMC8135227 OTO - NOTNLM OT - CCL2 OT - COVID-19 OT - Cancer OT - Endothelial dysfunction OT - Monocyte chemoattractant protein-1 OT - NF-kB OT - Oxidative stress COIS- The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. EDAT- 2021/07/09 06:00 MHDA- 2021/12/21 06:00 PMCR- 2021/05/20 CRDT- 2021/07/08 05:47 PHST- 2021/01/22 00:00 [received] PHST- 2021/02/25 00:00 [revised] PHST- 2021/03/17 00:00 [accepted] PHST- 2021/07/09 06:00 [pubmed] PHST- 2021/12/21 06:00 [medline] PHST- 2021/07/08 05:47 [entrez] PHST- 2021/05/20 00:00 [pmc-release] AID - S1567-5769(21)00234-4 [pii] AID - 107598 [pii] AID - 10.1016/j.intimp.2021.107598 [doi] PST - ppublish SO - Int Immunopharmacol. 2021 Dec;101(Pt B):107598. doi: 10.1016/j.intimp.2021.107598. Epub 2021 May 20.